Send this to a friend

Biotech, pharma bring in the dollars in Mass.

More than one-third of all venture capital money invested in biopharmaceutical companies last year went to Massachusetts companies, with the bulk of those dollars headed to companies in Cambridge and nearby, according to a new industry report.
The Massachusetts Biotechnology Council on Wednesday released its annual Industry Snapshot, which tallied a total of $3.1 billion in venture investments in biopharma companies here in 2017, and another $2.7 b ...

Fields marked in red are required
Your name
Your email
Recipient addresses
(Separate multiple addresses with commas)

Personal message

ADVERTISEMENTS
Copyright 2017 New England Business Media